Double or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in...

Area of Science:

• Cardiology
• Thrombosis Management

Background:

• Atrial fibrillation patients often require anticoagulation plus antiplatelet therapy.
• Balancing bleeding and ischemic events in this high-risk group is complex.
• Optimal therapeutic strategies lack definitive evidence from large randomized trials.

Purpose of the Study:

• To review current evidence and expert recommendations for managing patients with atrial fibrillation on dual therapy.
• To highlight developments since the 2014 European Society of Cardiology (ESC) consensus and guidelines.
• To provide guidance on balancing antithrombotic therapy risks.

Main Methods:

• Literature review focusing on recent ESC guidelines and consensus documents.
• Analysis of recommendations concerning anticoagulation and antiplatelet therapy in atrial fibrillation.
• Synthesis of expert opinion and available evidence.

Main Results:

• The optimal antithrombotic strategy is debated due to a lack of specific large-scale trials.
• Recent guidelines emphasize individualized risk assessment for bleeding and ischemia.
• The review consolidates current understanding and expert consensus.

Conclusions:

• Current management relies on integrating guidelines and consensus documents for individualized patient care.
• Further research is needed to establish definitive evidence-based strategies.
• Careful consideration of bleeding and ischemic risk factors is paramount.